8-K: Colgate-Palmolive Achieves Record Net Sales in 2024, Reports Strong Full-Year and Fourth-Quarter Results

Sentiment:

Quarterly Report


Colgate-Palmolive reported record net sales exceeding $20 billion for 2024, alongside strong organic sales growth and increased earnings per share.

Better than expectedThe company exceeded its organic sales growth target for the sixth consecutive year.The company achieved record net sales exceeding $20 billion.The company reported a 27% increase in GAAP EPS for the full year.

Summary

  • Colgate-Palmolive's net sales reached over $20 billion for the first time in 2024, a 3.3% increase compared to 2023.
  • Organic sales grew by 7.4% for the full year, which includes a 0.5% negative impact from lower private label pet volume.
  • GAAP earnings per share (EPS) increased by 27% to $3.51, while base business EPS increased by 11% to $3.60.
  • The company generated $4.107 billion in net cash from operations, a 10% increase year-over-year.
  • Colgate returned $3.4 billion to shareholders through dividends and share repurchases.
  • In the fourth quarter, net sales decreased slightly by 0.1%, but organic sales increased by 4.3%.
  • Fourth-quarter GAAP EPS rose by 3% to $0.90, and base business EPS increased by 5% to $0.91.
  • Both GAAP and base business gross profit margins increased by 70 basis points to 60.3% in the fourth quarter.
  • Colgate maintained its global market leadership in toothpaste with a 41.4% market share and in manual toothbrushes with a 32.2% market share year-to-date.
  • The company expects roughly flat net sales for 2025, with organic sales growth within the 3% to 5% range.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong financial results, record sales, and positive future guidance. The company's performance exceeded expectations in several key areas, and management expressed confidence in future growth.

Positives

  • The company achieved record net sales exceeding $20 billion for the first time.
  • Organic sales growth was strong at 7.4% for the full year, surpassing the company's target range.
  • Both GAAP and base business EPS showed significant increases for the full year and fourth quarter.
  • Net cash from operations increased by 10% year-over-year.
  • The company demonstrated a commitment to returning value to shareholders through dividends and share repurchases.
  • Gross profit margins improved in the fourth quarter.
  • Colgate maintained its leadership in key product categories with strong global market share.
  • The company increased advertising spending to support brand health and innovation.
  • Colgate has built flexibility into its income statement to invest in digital and data analytics.
  • The company is well-positioned to deliver consistent earnings per share growth in 2025 and beyond.

Negatives

  • Net sales decreased slightly by 0.1% in the fourth quarter.
  • The company experienced a negative impact from lower private label pet volume.
  • Net sales in Latin America decreased by 7.2% in the fourth quarter.
  • Operating profit in North America decreased by 11% in the fourth quarter.
  • The company expects a mid-single-digit negative impact from foreign exchange on net sales in 2025.

Risks

  • The company faces potential headwinds from foreign exchange fluctuations.
  • The planned exit from private label pet nutrition will impact organic sales growth in 2025.
  • The company is exposed to macroeconomic uncertainties that could affect performance.
  • There are limitations on the availability of up-to-date market share information, particularly in e-commerce and certain retail channels.
  • The company's market share data may differ from that of other companies due to variations in category definitions and data sources.

Future Outlook

The company expects roughly flat net sales in 2025, with organic sales growth within the 3% to 5% range, including the impact of the planned exit from private label pet nutrition. They anticipate mid-single-digit earnings-per-share growth on a GAAP basis and low to mid-single-digit earnings-per-share growth on a non-GAAP basis.

Management Comments

  • Noel Wallace, Chairman, President and Chief Executive Officer, stated that the company delivered another quarter and full year of strong organic sales growth along with increases in gross profit, gross profit margin, net income, earnings per share and cash flow.
  • Management is pleased to have delivered peer leading growth while funding investment for future growth and building flexibility into the P&L to counter macro headwinds.
  • The company is well positioned to deliver against its guidance in 2025.
  • Reaching $20 billion in net sales for the year is an exciting milestone.
  • The quality of the results this year and the strong growth momentum add to the company's confidence that they are well positioned to deliver consistent, compounded earnings per share growth in 2025 and beyond.

Industry Context

Colgate-Palmolive's results reflect a strong performance in the consumer goods sector, particularly in oral care and pet nutrition. The company's focus on organic growth and brand investment aligns with industry trends emphasizing innovation and market leadership. The results indicate a strong competitive position in the global market.

Comparison to Industry Standards

  • Colgate's 7.4% organic sales growth for the full year is strong compared to many of its peers in the consumer staples sector, which often see growth in the low single digits.
  • Procter & Gamble, a major competitor, reported organic sales growth of 4% in their most recent quarter, placing Colgate ahead in terms of growth.
  • Unilever, another competitor, has also been focusing on organic growth, but their results have varied by region, making Colgate's consistent growth across all divisions notable.
  • The 15% increase in advertising spending demonstrates a commitment to brand building, which is a common strategy among leading consumer goods companies.
  • Colgate's market share in toothpaste and manual toothbrushes is a testament to its brand strength and product quality, setting a high benchmark for competitors.

Stakeholder Impact

  • Shareholders will benefit from increased earnings per share and continued dividends and share repurchases.
  • Employees are recognized for their hard work and dedication in achieving the company's goals.
  • Customers will continue to have access to the company's leading brands and products.
  • Suppliers will continue to have a strong business relationship with the company.
  • Creditors will see the company's strong financial position as a positive sign.

Next Steps

  • The company will continue to focus on organic sales growth and brand investment.
  • Colgate will manage the planned exit from private label pet nutrition.
  • The company will continue to invest in digital and data analytics capabilities.
  • Colgate will host a conference call to discuss the results.

Key Dates

DateDescription
January 31, 2025Date of the earnings release and 8-K filing.
May 9, 2025Currently scheduled date for the company's annual meeting of stockholders.

Keywords

Colgate-Palmolive, Net Sales, Organic Sales, EPS, Gross Profit Margin, Market Share, Consumer Goods, Oral Care, Pet Nutrition, Advertising Spending

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.